Read Larry Connors' blog – Short Term Trading Strategies
These two innovative dental companies have now combined to offer dental professionals an impressive line of dental care products. Zila, a division of TOLMAR, as the new company is called, provides a combined range of high-quality products surrounding consumable home care products, in-office diagnostics, acute care products, and prevention tools that allow dental professionals to effectively treat patients to the highest professional standards.
Dental professionals will continue to have access to the Zila products they are already familiar with such as the Rotadent(R) automatic toothbrush, the award-winning Pro-Select Platinum(R) scaler, and our deep line of products surrounding the Zila Soft Tissue Management(R) program.
In addition, we are proud to offer ATRIDOX(R), the only locally applied antimicrobial that is clinically proven and indicated for all three of these outcomes: gain in clinical attachment, reduction in probing depth, and reduction in bleeding on probing. Also, we are excited to continue the growth and market acceptance of our innovative and cost-efficient oral cancer screening product, ViziLite(R) Plus, which recently won a 2008 Hygiene Townie Choice Award.
"The new Zila has the financial stability, experience, products, and services to help dental professionals care for their patients while contributing to the success of their practice," said Mike Duncan, CEO of TOLMAR.
About TOLMAR Holding, Inc.
TOLMAR Holding, Inc. is a private pharmaceutical company. TOLMAR Inc. is a Colorado-based pharmaceutical research, development, manufacturing and commercial operations company. TOLMAR is responsible for the development and manufacturing of 18 prescription pharmaceutical products dispensed in the U.S. The company's dental division manufactures and distributes dental products designed to treat adult periodontal disease. TOLMAR's flagship brand, ATRIDOX(R), is the only locally applied antimicrobial that is clinically proven and indicated for all three of these outcomes: gain in clinical attachment, reduction in probing depth, and reduction in bleeding on probing. TOLMAR also manufactures and sells ATRISORB(R) FreeFlow(TM) and ATRISORB(R)-D FreeFlow(TM), which are bioabsorbable guided tissue regeneration barriers indicated for use in periodontal surgical procedures. ATRISORB-D is the only GTR barrier with doxycycline. For more information about the company, visit www.tolmar.com.
About Zila, Inc.
Zila, Inc., headquartered in Scottsdale, Arizona, is a diagnostic company dedicated to the prevention, detection and treatment of oral cancer and periodontal disease. Zila manufactures and markets ViziLite(R) Plus with TBlue(R) ("ViziLite(R) Plus"), the company's flagship product for the early detection of oral abnormalities that could lead to cancer. ViziLite(R) Plus is an adjunctive medical device cleared by the FDA for use in a population at increased risk for oral cancer. In addition, Zila designs, manufactures and markets a suite of proprietary products sold exclusively and directly to dental professionals for periodontal disease, including the Rotadent(R) Professional Powered Brush, the Pro-Select Platinum(R) ultrasonic scaler and a portfolio of oral pharmaceutical products for both in-office and home-care use. All of Zila's products are marketed and sold in the United States and Canada primarily through the company's direct field sales force and telemarketing organization. The company's products are marketed and sold in other international markets through the direct sales forces of third party distributors. Zila's marketing programs reach most U.S. dental offices.
For more information about the new Zila, please visit www.zila-dental.com.
To place an order for Zila products, including the Pro-Select Platinum(R) scaler, the Rotadent(R) automatic toothbrush, and ViziLite(R) Plus, please call 800-228-5595.
For TOLMAR product orders, including ATRIDOX(R), ATRISORB(R) and ATRISORB(R)-D, please call 877-TOLMAR1 (877-865-6271).
SOURCE: Zila, Inc.
Zila, Inc. Gary Klinefelter, 602-200-3249 gklinefelter@zila.com
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.
